Cargando…

Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria

Detalles Bibliográficos
Autores principales:	Ruf, Marie-Thérèse, Steffen, Christina, Bolz, Miriam, Schmid, Peter, Pluschke, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810495/ https://www.ncbi.nlm.nih.gov/pubmed/28873327 http://dx.doi.org/10.1080/21505594.2017.1370530

Ejemplares similares

Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions
por: Ogbechi, Joy, et al.
Publicado: (2015)

What about Current Diversity of Mycolactone-Producing Mycobacteria? Implication for the Diagnosis and Treatment of Buruli Ulcer
por: Combe, Marine, et al.
Publicado: (2023)

Immunohistochemical Monitoring of Wound Healing in Antibiotic Treated Buruli Ulcer Patients
por: Andreoli, Arianna, et al.
Publicado: (2014)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions
por: Hsieh, Louise Tzung-Harn, et al.
Publicado: (2022)

Distribution and Risk of Mycolactone-Producing Mycobacteria Transmission within Buruli Ulcer Endemic Communities in Côte d’Ivoire
por: Dassi, Christelle, et al.
Publicado: (2017)

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease
por: Niang, Fatoumata, et al.
Publicado: (2015)

Molecular Characterization of Mycolactone Producing Mycobacteria from Aquatic Environments in Buruli Ulcer Non-Endemic Areas in Côte d’Ivoire
por: Tano, Marcellin B., et al.
Publicado: (2017)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer
por: En, Junichiro, et al.
Publicado: (2017)

Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring
por: Sarfo, Fred S., et al.
Publicado: (2011)

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease
por: Sarfo, Fred Stephen, et al.
Publicado: (2015)

RNA Aptamer That Specifically Binds to Mycolactone and Serves as a Diagnostic Tool for Diagnosis of Buruli Ulcer
por: Sakyi, Samuel A., et al.
Publicado: (2016)

Local Heat Application for the Treatment of Buruli Ulcer: Results of a Phase II Open Label Single Center Non Comparative Clinical Trial
por: Vogel, Moritz, et al.
Publicado: (2016)

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer
por: Dreyer, Anita, et al.
Publicado: (2015)

Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment
por: Scherr, Nicole, et al.
Publicado: (2015)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2020)

Geographic Distribution, Age Pattern and Sites of Lesions in a Cohort of Buruli Ulcer Patients from the Mapé Basin of Cameroon
por: Bratschi, Martin W., et al.
Publicado: (2013)

A Case of Cutaneous Tuberculosis in a Buruli Ulcer–Endemic Area
por: Bratschi, Martin W., et al.
Publicado: (2012)

Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

Development of Highly Organized Lymphoid Structures in Buruli Ulcer Lesions after Treatment with Rifampicin and Streptomycin
por: Schütte, Daniela, et al.
Publicado: (2007)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy with Streptomycin and Rifampicin
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2013)

Histopathological Changes and Clinical Responses of Buruli Ulcer Plaque Lesions during Chemotherapy: A Role for Surgical Removal of Necrotic Tissue?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

Mycolactones: immunosuppressive and cytotoxic polyketides produced by aquatic mycobacteria
por: Hong, Hui, et al.
Publicado: (2008)

Cellular Immunity Confers Transient Protection in Experimental Buruli Ulcer following BCG or Mycolactone-Negative Mycobacterium ulcerans Vaccination
por: Fraga, Alexandra G., et al.
Publicado: (2012)

Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
por: Tobias, Nicholas J., et al.
Publicado: (2009)

Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology
por: Foulon, M., et al.
Publicado: (2020)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Correction: Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
por: Tobias, Nicholas J., et al.
Publicado: (2010)

Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer
por: Anand, U, et al.
Publicado: (2016)

Single Nucleotide Polymorphism Typing of Mycobacterium ulcerans Reveals Focal Transmission of Buruli Ulcer in a Highly Endemic Region of Ghana
por: Röltgen, Katharina, et al.
Publicado: (2010)

Buruli Ulcer in Cameroon: The Development and Impact of the National Control Programme
por: Tabah, Earnest Njih, et al.
Publicado: (2016)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer
por: Bolz, Miriam, et al.
Publicado: (2016)

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)

The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer
por: Hall, Belinda S., et al.
Publicado: (2022)

Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer
por: Akolgo, Gideon A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oio9r89kbc93bd83o3asf7b9gr